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Abstract 
 
This study includes the Synthesis of Azoles Based p-Toluic Acid Derivative. The compounds were prepared by 
reaction of p-Toluic Acid with thiosemicarbazide in the presence of Phosphorus oxychloride to yield 1, 3, 4-
thiadiazole nucleus. Further this thiadiazole was treated with different aromatic aldehydes in presence of methanol 
to yield corresponding Schiff’s bases. All the Schiff’s bases thus obtained were reacted with Thioglycolic acid to 
yield the title compounds. Synthesized derivatives were characterized by IR, H
1
NMR and screened for their 
antibacterial (S. aureus, B. subtilis, E. coli, and P. aerugiosa) and antifungal activity (A. Niger and C. albicans). 
Key Words: Azole derivative, p-Toluic Acid derivative, antimicrobial activity 
Introduction 
Medicine is a system of scientific knowledge and 
practical activities aimed at preserving and improving 
the health of people, prevention and treatment of 
human disease. [1]. This would serve as the basis for 
ensuring good health for a community Traditional 
Indian medicine-a conglomerate of Ayurveda, Sidha 
and Unani has a long history The 4-thiazolidinones that 
do not contain aryl or higher alkyl substituents are 
somewhat soluble in water or thiazolidinone that do not 
contain aryl or higher alkyl substituents are somewhat 
less soluble in water[2] Thiadiazole is a heterocyclic 
compound featuring both a nitrogen and sulphur atom 
as a part of the aromatic five membered rings. It acts as 
Hydrogen bonding domain and two electron donor 
moiety along with ability of Bio-isosteric replacement 
of thiazole moiety. Bioisosteres are atoms or group of 
molecules that fit the broadest definition for isosteres. 
[3-5]. 
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Thiazole is resistant to oxidizing agents; even hot nitric 
acid has little effect. It is either unaffected by reducing 
agents or at most some ring opening occurs it is 
therefore not possible to make dihydrothiazoles or 
thiazolidines by catalytical dehydrogenation but they 
must need to be prepared by means of condensation 
reactions. Thiazole is of great biological importance as 
it is used as an intermediate to manufacture synthetic 
drugs, fungicides and dyes. A thiazole ring is found in 
the essential vitamin B1 [7].  The literature survey 
showed that the Thiadiazole moiety exhibit 
antimicrobial, anti cancer, anti inflammatory, 
antioxidant Anti Fungal, anti depressant, anti-
Anthelmintic activity. [8-13]. Considerable confusion 
concerning the structure of 4-thiazolidinones exist in 
the early literature and non cyclic formulas were at first 
proposed for pseudo thiohydantoin and for 
rhodanine1,4-thiazolidinones are derivatives of 
thiazolidine with a carbonyl group at the  4
th
 position. 
Substitution is possible at 2, 3 and 5 positions various 
optical and geometrical isomers are reported [19].The 
initial synthetic route is not economical enough for 
providing sufficiently quantity of the 1,3-thiazolidin-4-
one intermediate and the authors developed an 
improvement by protection of alanine with chloro 
trimethylsilane (TMSCl). The direct condensation of 
aldehydes, alanine and mercaptoacetic acid give the 
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desired thiazolidinone along with the dithioacetal as 
the major byproduct [20]. 
 
Materials and Methods 
The chemical used for experimental were of synthetic 
grade and procured from Nice Laboratory, Loba 
Chemie Private Limited, CDH New Delhi and 
Research Lab Fine Chem industries Mumbai. The 
melting points of the synthesized compounds were 
determined in open glass capillaries and are 
uncorrected. IR spectra were recorded on FTIR 
Spectrometer. H
1
NMR spectra were recorded on were 
recorded in CDCl3/DMSO solution on a Bruker 
Avance II 400 MHz NMR spectrometer taking 
Tetramethylsilane (TMS) as internal standard. Progress 
of reaction was monitored by TLC using solvent 
Hexane: Ethyl acetate (40%) & Methanol: Chloroform 
(1%). 
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Synthetic procedure 
Synthesis of 5-p-tolyl-1, 3, 4-thiadiazol-2-amine 
A mixture of equimolar quantity of p-Toluic Acid 
(50mmol) and thiosemicarbazide (50 mmol) were 
refluxed in 20 ml POCl3 solution for 2 h at 75
0
C. After 
cooling down to room temperature, cold water was 
added. The mixture was again refluxed for 4 h. The 
content was cooled down at room temperature and 
made alkaline at pH 8.0 by addition of 50 % NaOH 
solution. The solid (5-p-tolyl-1, 3, 4-thiadiazol-2-
amine) (compound 3) so obtained was filtered and 
recrystallized using ethanol. (Bhatia et al) 
Synthesis of Schiff bases 
In this step compound 3 i.e. 5-p-tolyl-1, 3, 4-thiadiazol-
2-amine was refluxed with different substituted 
aromatic aldehydes (0.025M) [a-k] using methanol (50 
mL) as solvent in presence of small amount of glacial 
acetic acid for 2 hrs. The mixture was cooled and 
poured in ice water. The content was put undisturbed 
for 24h. The solid thus obtained was separated by 
filtration and recrystallized from Methanol to give the 
Corresponding Schiff bases (a-k). [Kumar et al 2011 
and Kumar et al 2018] 
Synthesis of thaizolidinone 
A mixture of Synthesized Schiff base (0.02M) (a-k) 
and Thioglycolic acid (0.02M) in 50ml DMF, 
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containing a pinch of anhydrous ZnCl2 were refluxed 
for about 6 hrs. The reaction mixture was cooled and 
poured on to crushed ice. The solid thus obtained was 
filtered, washed with water and the product 
thaizolidinone (6a-k) was recrystallized from ethanol. 
[Sharma et al 2010]. 
Characterization of synthesized compounds 
 
Compound 1 
2-(4-chloro-phenyl)-3-(5-p-tolyl-[1, 3, 4]-thiadiazol-
2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
): 3014.1 (C-H str, aromatic), 2985.5 (C-
H str, alkane), 1674.4 (C=O str.), 1636.9 (C=N str.), 
1284.1 (C-N), 835.40(C-Cl). 
 
1H NMR (DMSO) (δ-ppm):  7.05-7.55 (8H, Ar H); 5.7 
(1H, N-CH); 3.6 (1H, CH-S); 2.31(3H, s, CH3). 
Compound 2 
2-(2-Fluoro-phenyl)-3-(5-p-tolyl-[1, 3, 4]-thiadiazol-
2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
): 3012.8 (C-H str, aromatic), 2987.4 (C-
H str, alkane), 1671.6 (C=O str.), 1637.5 (C=N str.), 
1284.6 (C-N) 
 
1H NMR (DMSO) (δ-ppm):  6.9-7.45 (8H, Ar H); 5.74 
(1H, N-CH); 3.45 (1H, CH-S); 2.28(3H, s, CH3) 
Compound 3 
2-(2-Nitrophenyl)-3-(5-p-tolyl-[1, 3, 4]-thiadiazol-2-
yl)-thiazolidin-4-one  
IR (KBr) (cm
-1
): 3007.1 (C-H str, aromatic), 2988.4 (C-
H str, alkane), 1670.6 (C=O str.), 1636.3 (C=N str.), 
1285.0 (C-N) 
 
1H NMR (DMSO) (δ-ppm):  7.2-7.85 (8H, Ar H); 5.9 
(1H, N-CH); 3.47 (1H, CH-S); 2.30(3H, s, CH3) 
 
Compound 4 
2-(3-hydroxy-phenyl)-3-(5-p-tolyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
):3385.18 (O-H str.), 3009.05 (C-H str, 
aromatic), 2981.56 (C-H str, alkane), 1668.62 (C=O 
str.), 1635.54 (C=N str.), 1280.74 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 6.78-7.51(8H, m, Ar-H); 
5.88 (1H, s, N-CH); 4.8 (1H, s, OH), 3.44 (1H,s, CH-
S); 2.26 (3H, s, CH3) 
Compound 5 
2-(4-Hydroxy-phenyl)-3-(5-p-tolyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
):3384.42 (O-H str.), 3010.12 (C-H str, 
aromatic), 2981.09 (C-H str, alkane), 1667.84 (C=O 
str.), 1635.31 (C=N str.), 1281.04 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 6.74-7.48 (8H,m, Ar-H); 
5.86 (1H, s, N-CH); 4.91 (1H,s, OH), 3.42 (1H,s, CH-
S); 2.27 (3H, s, CH3) 
 
 
Compound 6 
2-(2-Methoxy-phenyl)-3-(5-p-tolyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
): 3018.10 (C-H str, aromatic), 2978.29 
(C-H str, alkane), 1668.08 (C=O str.), 1637.49 (C=N 
str.), 1285.04 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 6.87-7.62 (8H, m, Ar-H); 
5.89 (1H, s, N-CH); 3.76 (3H,s,-OCH3), 3.45(1H, 
s,CH-S); 2.29 (3H, s, CH3) 
Compound 7 
2-(4-Methoxy-phenyl)-3-(5-p-tolyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
): 3016.2 (C-H str, aromatic), 2978.45 
(C-H str, alkane), 1669.18 (C=O str.), 1636.11 (C=N 
str.), 1283.47 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 6.85-7.71 (8H, m, Ar-H); 
5.86 (1H, s, N-CH); 3.78 (3H,s, -OCH3), 3.41(1H,s, 
CH-S); 2.33 (3H, s, CH3) 
Compound 8 
2-Phenyl-3- (5-p-tolyl-[1, 3, 4]-thiadiazol-2-yl)-
thiazolidin-4-one 
IR (KBr) (cm
-1
): 3013.8 (C-H str, aromatic), 2977.95 
(C-H str, alkane), 1666.09 (C=O str.), 1631.65 (C=N 
str.), 1277.06 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 7.08-7.82 (9H, m, Ar-H); 
5.86 (1H, s, N-CH); 3.78 (3H, s, -OCH3), 3.41(1H, s, 
CH-S); 2.33(3H, s, CH3) 
Compound 9 
2-(2, 4-Dichloro-phenyl-3- (5-p-tolyl-[1, 3, 4]-
thiadiazol-2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
): 3022.03 (C-H str, aromatic), 2979.05 
(C-H str, alkane), 1668.11 (C=O str.), 1630.25 (C=N 
str.), 1278.94 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 7.05-7.81 (7H, m, Ar-H); 
5.85 (1H, s, N-CH); 3.49 (1H, s, CH-S); 2.35(3H, s, 
CH3) 
Compound 10 
2-(4-Nitro-phenyl-3- (5-p-tolyl-[1, 3, 4]-thiadiazol-2-
yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
): 3020.0 (C-H str, aromatic), 2982.24 
(C-H str, alkane), 1673.52 (C=O str.), 1635.74 (C=N 
str.), 1277.5 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 7.15-8.01 (8H, m, Ar-H); 
5.89 (1H, s, N-CH); 3.37 (1H, s, CH-S); 2.28(3H, s, 
CH3) 
Compound 11 
2-(2-Bromo-phenyl-3- (5-p-tolyl-[1, 3, 4]-thiadiazol-
2-yl)-thiazolidin-4-one 
IR (KBr) (cm
-1
): 3021.08 (C-H str, aromatic), 2978.51 
(C-H str, alkane), 1670.14 (C=O str.), 1634.56 (C=N 
str.), 1274.6 (C-N) 
 
1H NMR (DMSO) (δ-ppm): 7.02-7.96 (8H, m, Ar-H); 
5.83 (1H, s, N-CH); 3.39 (1H, s, CH-S); 2.29(3H, s, 
CH3). 
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Biological Activity 
Keeping in view the activity profile of Thiazolidinone 
and Thiadiazole itself, it was thought sensible to carry 
out biological screening of all the newly synthesized 
compounds. Therefore all the synthesized compounds 
were subjected to Antimicrobial evaluation. 
 
Antibacterial activity 
 
The antibacterial activities of compounds were 
determined in vitro against Gram-positive 
(Staphylococcus aureus, Bacillus subtilis) and Gram-
negative (Escherichia coli, P. aeuroginosa) bacteria by 
tube dilution method. Double strength nutrient broth- 
(I.P.) media and sabourand’s glucose broth media- 
(I.P.) were used for bacteria and fungi respectively. 
The samples were incubated at 37 °C for 24 h 
(bacteria), at 25 °C for 7 d (A. Niger) and at 37 °C for 
48 h (C. albicans) and the results were recorded in 
terms of minimum inhibitory concentration (MIC). 
Ciprofloxacin and fluconazole were taken as standard 
drugs for antibacterial and antifungal activity, 
respectively.  
 
Determination of MIC 
 
MIC of compounds was determined by two fold serial 
dilution technique. Dilution of test compound and 
standard drugs were prepared in test medium to give a 
concentration of 50, 25, 12.5, 6.25, 3.125 and 1.56 
µg/ml from stock solution (100µg/ml). All the samples 
were inoculated with 0.1ml suspension of bacteria in 
saline and incubated at required temperature. MIC was 
determined by lowest concentration of sample that 
prevents the development of turbidity. [18] The 
observed MIC is presented in Table 1. 
 
Table 1: Minimum Inhibitory Concentration (MIC) of different compounds 
 
Comp- 
ounds 
 
Minimum Inhibitory Concentration (MIC) 
Bacterial strains Fungal strains 
Gram Positive Gram Negative 
S. aureus B. subtilis P. aeruginosa E.coli C. albicans A. niger 
1 1.610 1.610 1.610 1.610 1.610 1.610 
2 0.842 0.842 0.842 0.842 0.842 0.842 
3 1.570 1.570 0.785 0.785 1.570 1.570 
4 1.689 1.689 1.689 1.689 1.689 1.689 
5 1.689 1.689 1.689 1.689 1.689 1.689 
6 1.74 1.74 1.74 1.74 0.870 0.870 
7 1.74 1.74 1.74 1.74 0.870 0.870 
8 1.77 1.77 1.77 1.77 1.77 1.77 
9 0.740 0.740 0.740 0.740 1.48 1.48 
10 1.570 1.570 0.785 0.785 1.570 1.570 
11 0.723 0.723 0.723 0.723 0.723 0.723 
Std.  0.471 0.471 0.471 0.471 0.510 0.510 
Standard: ciprofloxacin (antibacterial) and fluconazole (antifungal). 
 
Result and discussion 
The Title compounds were synthesized as per the 
procedure mentioned under heading Synthetic 
procedure.  The synthesized compounds were 
recrystallized and purity of the compounds was 
ascertained by using appropriate solvent systems (ethyl 
acetate: benzene: water). The compounds were 
characterized by their IR and NMR spectroscopic data.  
 
The result of IR and HNMR data are in good 
agreement with their theoretical values. The 
Physiochemical data of Synthesized Thiazolidinone 
derivatives is presented in table 2. Compounds 2, 3, 6, 
7,9,10, 11 showed the significant antimicrobial activity 
against different strains of microbes. 
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Table 2: Characterization (Physiochemical) data of compounds 
 
Conclusion 
In the present work two azole containing moiety i.e. 
Thiadiazole and Thiazolidinone were clubbed to obtain 
their synergistic effect and evaluated for their 
antimicrobial effect. The experimental data of the 
present research work reveals that synthesized azole 
derivatives of demonstrate significant Antibacterial and 
Antifungal Activity. Compound 2, 3, 6, 7,9,10, 11 
showed significant antimicrobial activity (table 1) 
Further, it has been observed that Thiadiazole which 
are substituted by halogen (-Cl, -Br, -F) with electron 
withdrawing property exhibits more Antimicrobial 
activity than the other.  
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